181 related articles for article (PubMed ID: 28677170)
1. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
[TBL] [Abstract][Full Text] [Related]
3. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
4. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
5. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
[TBL] [Abstract][Full Text] [Related]
6. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
[TBL] [Abstract][Full Text] [Related]
7. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.
Inamura K; Takeuchi K; Togashi Y; Hatano S; Ninomiya H; Motoi N; Mun MY; Sakao Y; Okumura S; Nakagawa K; Soda M; Choi YL; Mano H; Ishikawa Y
Mod Pathol; 2009 Apr; 22(4):508-15. PubMed ID: 19234440
[TBL] [Abstract][Full Text] [Related]
8. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
9. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Genova SN; Belovezhdov VT; Bichev SN; Danev VH
Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186
[TBL] [Abstract][Full Text] [Related]
10. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K
Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891
[TBL] [Abstract][Full Text] [Related]
11. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features.
Kawai H; Miura T; Kawamatsu N; Nakagawa T; Shiba-Ishii A; Yoshimoto T; Amano Y; Kihara A; Sakuma Y; Fujita K; Shibano T; Ishikawa S; Ushiku T; Fukayama M; Tsubochi H; Endo S; Hagiwara K; Matsubara D; Niki T
Virchows Arch; 2024 May; ():. PubMed ID: 38710944
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
[TBL] [Abstract][Full Text] [Related]
14. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
[No Abstract] [Full Text] [Related]
15. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
[TBL] [Abstract][Full Text] [Related]
16. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
[TBL] [Abstract][Full Text] [Related]
17. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.
Zamboni M; Civitareale D
Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701
[TBL] [Abstract][Full Text] [Related]
18. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D
J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434
[TBL] [Abstract][Full Text] [Related]
19. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
[TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
